Research

Endeavor reports phase 2b success for potential IPF drug

Endeavor said its mid-stage IPF trial succeeded, with results suggesting the drug could reduce lung fibrosis and increase total lung capacity.

Reported by 2 outlets Thursday, October 8, 2026

The original reports on this story are listed below.

Reporting on this story

More top stories

This Week in Medicine

The week in medicine, in five minutes

The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.

Free. No spam. Unsubscribe anytime.